Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2020
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
HAI Follows Dutch Government Advice in Response to COVID-19
2018
What Role Can Civil Society Play in the European Regulatory Process?
Open Science for Health: Shaping the New Framework Programme
2017
EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines
European Commission Appoints Health Action International to HTA Network Stakeholder Pool
2016
Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit
2015
HAI urges MEPs to support key amendments to TTIP resolution
The EU-US Trade Deal Could Leave Europeans Sick
2014
EMA policy on clinical data publication a step ahead, but falls short of true potential
Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry
Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA
2011
DG Trade State of Play reveals EU's ambitions for IP protection in FTAs
2010